Founded: Seattle WA United States (1977)

Organization Overview

First Clinical Trial
2003
NCT00317473
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

PATH | PATH Malaria Vaccine Initiative | PATH-Malaria Vaccine Initiative (PATH-MVI) | PATH Vaccine Solutions | The PATH Malaria Vaccine Initiative (MVI)